Distributions from private equity funds in Asia, which have in the past been lackluster compared to those in certain developed markets, are expected to rise as the industry matures and GPs develop their skill sets.
"Distributions have exceeded capital calls for two years, but over the past vintages DPIs [distributed to paid in] have not been very high," Yong-Hak Huh, founder and CEO of First Bridge Strategy told...
Even if pan-Asian buyout firms aren't actively pursuing investments in internet-related businesses, they cannot ignore the potential disruptive impact of these technologies on other portfolio companies
Mekong Capital's 6.3x return on its investment in Vietnam-based pharmaceuticals player Traphaco involved turning the company's distribution model on its head, as well as supporting expansion and improving governance
China Renaissance has added dedicated healthcare and mezzanine debt strategies to its existing growth-stage private equity offering as part of efforts to more than treble its assets under management (AUM) over the next three years.
China Venture Capital Fund, a VC vehicle backed by the Chinese government, and ChinaEquity Group have jointly led a RMB670 million ($101 million) round for 3D Medicines, which focuses on personalized diagnostics and treatment for cancer.